Prognostic factors and survival outcomes in colorectal cancer: insights from a Ghanaian cohort

结直肠癌的预后因素和生存结果:来自加纳队列研究的启示

阅读:2

Abstract

BACKGROUND: Colorectal cancer (CRC) incidence in Ghana has increased significantly in recent years. Despite medical advances, survival rates remain low, with challenges in CRC screening implementation contributing to late-stage diagnoses and poor outcomes. METHODS: This study updates CRC survival estimates and identifies key prognostic factors influencing outcomes in a Ghanaian cohort. We conducted a retrospective analysis of 281 CRC patients diagnosed between 2016 and 2022 at Komfo Anokye Teaching Hospital in Kumasi, Ghana. Data on patient demographics, tumour characteristics, and clinical variables were collected. Survival estimates were calculated using the Kaplan-Meier method, and the log-rank test was used to compare overall survival (OS). Multivariable Cox proportional hazards models identified independent prognostic factors. RESULTS: The median patient age was 54 years (95% CI: 53-58), with 27.8% under 45 years. Tumours were located in the colon (42.0%) and rectum (41.6%), with adenocarcinomas comprising 89.0% of cases. Stage III and IV diagnoses accounted for 39.1% and 29.9% of cases, respectively. There were 38.8% deaths, with a median OS of 45 months (95% CI: 32.5-57.5) and a 5-year OS rate of 39.3% (95% CI: 28.7-49.9). Poor OS was independently associated with stage II [aHR = 13.50, (95% CI: 1.74-104.75)], stage IV [aHR = 10.41, (95% CI: 1.16-93.11)], smoking [aHR = 1.72, (95% CI: 1.06-2.81)], multiple comorbidities [aHR = 2.72, (95% CI: 1.15-6.46)], and treatment with herbal medicine [aHR = 1.58, (95% CI: 1.04-2.38)]. Working in the informal sector was linked to improved OS [aHR = 0.57, (95% CI: 0.36-0.89)]. CONCLUSIONS: CRC survival rates in this cohort were low, with a substantial proportion of patients experiencing mortality within five years following diagnosis. The findings highlight the critical need for early detection and intervention, particularly in younger populations to improve survival outcomes.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。